Insights+ Key Biosimilars Events of June 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Mylan with its partners Lupin and Biocon received MAA for Nepexto (biosimilar, etanercept) in EU and the US FDA's Approval for Semglee (biosimilar, insulin glargine) respectively Our team at PharmaShots has summarized 15 key events of the…

BySenior EditorJuly 3, 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – June 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…

BySenior EditorJune 30, 2020

VIEWPOINTS

PharmaShots Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19

In an interview with PharmaShots, Brian Finrow, Co-Founder and CEO of Lumen Bioscience shared his views on the critical need for a scalable and cheaper method to engineer antibodies as a potential treatment for Covid-19. He also shed light on why it is time for the industry to reevaluate plant-based biologics manufacturing as a possible way to…

BySenior EditorJune 26, 2020

THOUGHTSPOT

Virtual Clinical Trials – Are They the Future of India?

2020 is a year that nobody ever thought could turn their lives upside down. The beginning of this year witnessed the worldwide onset of Coronavirus disease or COVID-19 that has till now infected millions of people around the globe killing tens of thousands. In March 2020, WHO declared it to be a pandemic. There has…

BySenior EditorJune 25, 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in May 2020

The US FDA has approved multiple NDAs and BLAs in May 2020, leading to the treatments for patients and advances in the health care industry The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 43 novel products so far in 2020, including 12 in May 2020…

BySenior EditorJune 19, 2020

EVENTS

Exclusive Webinar: Strategies to Conduct Clinical Trials Effectively in Covid-19 Era

The Webinar on 'Strategies to Conduct Clinical Trials effectively in Covid-19 era' organized by CliniMed LifeSciences Pvt. Ltd., Kolkata in association with Indian Society for Clinical Research (ISCR) and Peerless Hospital, Kolkata as knowledge partners and PharmaShots as a media partner, was held at 3 pm on June 6, 2020. Around 500 plus participants attended…

BySenior EditorJune 18, 2020

INSIGHTS+

Insights+ Key Biosimilars Events of May 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Fresenius Kabi expanded its footprints with the acceptance of MAA and BLA of its MSB11455 (biosimilar, pegfilgrastim) in the EU and the US respectively, and also signed an agreement with Medec to commercialize Idacio (adalimumab, biosimilar) in…

BySenior EditorJune 5, 2020

EVENTS

Strategies to Conduct Clinical Trials effectively in Covid-19 era

Claimed LifeSciences Pvt. Ltd., Kolkata is gladly organizing a Webinar on Strategies to Conduct Clinical Trials effectively in Covid-19 era in association with Indian Society for Clinical Research (ISCR) and Peerless Hospital, Kolkata as knowledge partners. The objective of this insightful webinar is to promote discussion among all stakeholders of clinical trials in the country…

BySenior EditorJune 5, 2020

INSIGHTS+

Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20

The American Society of Clinical Oncology (ASCO) is a platform for cancer experts to share views on the latest advancements and new approaches in cancer research and was held virtually this year due to the COVID-19 pandemic Janssen highlights its oncology portfolio, Merck & Pfizer demonstrated the potential of Bavencio in GTT while AstraZeneca showcased…

BySenior EditorJune 1, 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019 PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…

BySenior EditorMay 29, 2020

Senior Editor

Insights+ Key Biosimilars Events of June 2020

Insights+: COVID-19 Healthcare News Monthly Updates – June 2020

PharmaShots Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19

Virtual Clinical Trials – Are They the Future of India?

Insights+: The US FDA New Drug Approvals in May 2020

Exclusive Webinar: Strategies to Conduct Clinical Trials Effectively in Covid-19 Era

Insights+ Key Biosimilars Events of May 2020

Strategies to Conduct Clinical Trials effectively in Covid-19 era

Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Contact US

FOLLOW US